-
Health todayObesity, diabetes and GLP-1 new
Tirzepatide reduced BMI by 18.5% over 72 weeks in adolescents with obesity
In 160 adolescents with obesity, weekly tirzepatide cut BMI by 18.5% over 72 weeks, against a 0.5% rise with placebo.
Peer-reviewed